TrialPanorama/TrialPanorama-database huggingface dataset:
Study: 24266969

Group type: EXPERIMENTAL
Intervention: Sirolimus (SRL)
Number of subjects: 297

Group type: COMPARATOR
Intervention: Tacrolimus (TAC)
Number of subjects: 297

Group type: COMPARATOR
Intervention: Tacrolimus (TACex)
Number of subjects: 297
Study: 21179038

Group type: EXPERIMENTAL
Intervention: Direct mailing of self-sampler
Number of subjects: 619

Group type: EXPERIMENTAL
Intervention: Self-sampler at request
Number of subjects: 619

Group type: COMPARATOR
Intervention: HPV test at clinic
Number of subjects: 619

Group type: COMPARATOR
Intervention: Standard recall letters (Pap-test)
Number of subjects: 619
Study: 18307594

Group type: EXPERIMENTAL
Intervention: Lamivudine (LAM; 100 mg, q.d.)
Number of subjects: 39

Group type: EXPERIMENTAL
Intervention: Interferon (IFN; 9 MU, t.i.w.)
Number of subjects: 39

Group type: EXPERIMENTAL
Intervention: Interferon + Lamivudine combination (2 months of LAM followed by combination treatment)
Number of subjects: 39

Group type: COMPARATOR
Intervention: Interferon monotherapy
Number of subjects: 39

Group type: COMPARATOR
Intervention: Lamivudine monotherapy
Number of subjects: 39
Study: 16451437

Group type: EXPERIMENTAL
Intervention: School-based caries preventive program including intensive oral hygiene instructions and supervised daily tooth brushing with fluoridated toothpaste.
Number of subjects: 856

Group type: COMPARATOR
Intervention: Control group receiving only oral hygiene instructions sessions.
Number of subjects: 856
Study: 12954659

Group type: EXPERIMENTAL
Intervention: Testosterone replacement therapy
Number of subjects: 2

Group type: COMPARATOR
Intervention: Placebo treatment in eugonadal men
Number of subjects: 2

Group type: EXPERIMENTAL
Intervention: Testosterone treatment
Number of subjects: 2

Group type: EXPERIMENTAL
Intervention: Self-report diary assessment
Number of subjects: 2
Study: 10615721

Group type: EXPERIMENTAL
Intervention: Semi‐Structured Assessment for the Genetics of Alcoholism (SSAGA)
Number of subjects: 80

Group type: COMPARATOR
Intervention: Schedule for Clinical Assessment in Neuropsychiatry (SCAN)
Number of subjects: 80
Study: 8948943

Group type: EXPERIMENTAL
Intervention: Study group (455 patients)
Number of subjects: 455

Group type: COMPARATOR
Intervention: Validation group (163 patients)
Number of subjects: 455

Group type: EXPERIMENTAL
Intervention: Predictive equation for burn infection
Number of subjects: 455

Group type: EXPERIMENTAL
Intervention: Risk factors identified
Number of subjects: 455
Study: 1757614

Group type: EXPERIMENTAL
Intervention: 0.05% halobetasol propionate ointment
Number of subjects: 224

Group type: COMPARATOR
Intervention: Vehicle
Number of subjects: 224
Study: 6805647

Group type: EXPERIMENTAL
Intervention: Adrenergic-blocking agents (propranolol and phentolamine or propranolol alone) for three weeks
Number of subjects: 148

Group type: COMPARATOR
Intervention: Long-acting propranolol
Number of subjects: 148
Study: 30924762

Group type: EXPERIMENTAL
Intervention: Direct EVT
Number of subjects: 200

Group type: COMPARATOR
Intervention: Bridging therapy (EVT with IVT)
Number of subjects: 200
Study: 28069629

Group type: EXPERIMENTAL
Intervention: Nasogastric (NG) tube placement (with aspiration and lavage)
Number of subjects: 140

Group type: COMPARATOR
Intervention: No NG placement (control)
Number of subjects: 140
Study: 26180227

Group type: EXPERIMENTAL
Intervention: Transtheoretical-model tailored, computer-assisted intervention, stage-matched manual, brief counseling, and 10-week post-hospitalization nicotine replacement
Number of subjects: 100

Group type: COMPARATOR
Intervention: Usual care (on-unit nicotine replacement plus quit advice)
Number of subjects: 100
Study: 24321149

Group type: EXPERIMENTAL
Intervention: Voice Handicap Index (VHI)
Number of subjects: 36

Group type: EXPERIMENTAL
Intervention: Grade Roughness Breathiness Asthenia Strain (GRBAS) scale
Number of subjects: 36

Group type: EXPERIMENTAL
Intervention: Expanded Disability Status Scale (EDSS)
Number of subjects: 36
Study: 21603988

Group type: EXPERIMENTAL
Intervention: Oil-in-water emulsion (WO1932)
Number of subjects: 66

Group type: COMPARATOR
Intervention: Untreated group
Number of subjects: 66
Study: 20095333

Group type: EXPERIMENTAL
Intervention: Atorvastatin 20 mg/d
Number of subjects: 1275

Group type: COMPARATOR
Intervention: Pravastatin 20 mg/d
Number of subjects: 1275
Study: 16464721

Group type: EXPERIMENTAL
Intervention: Adenosine gated single photon emission computed tomography perfusion imaging at years 1 and 3
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Therapy (specifics not provided)
Number of subjects: 0
Study: 15561052

Group type: EXPERIMENTAL
Intervention: Arterial line leukocyte-depleting filter
Number of subjects: 110

Group type: COMPARATOR
Intervention: Standard arterial line filter (Control)
Number of subjects: 110
Study: 11940752

Group type: EXPERIMENTAL
Intervention: Colforsin daropate (0.75 microg x kg(‐1) x min(‐1) continuous infusion for 60 min)
Number of subjects: 36

Group type: COMPARATOR
Intervention: Normal saline (7.5 mL/hr continuous infusion)
Number of subjects: 36
Study: 9806696

Group type: EXPERIMENTAL
Intervention: 60 mg oral dextromethorphan
Number of subjects: 37

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 37
Study: 8529331

Group type: EXPERIMENTAL
Intervention: Fosinopril (intravenous and oral)
Number of subjects: 10

Group type: EXPERIMENTAL
Intervention: Fosinopril (oral)
Number of subjects: 10
Study: 2131458

Group type: EXPERIMENTAL
Intervention: Chewable tablets containing pyridoxine and heat‐killed lactic bacteria
Number of subjects: 245

Group type: COMPARATOR
Intervention: Placebo tablets with pyridoxine only
Number of subjects: 245
Study: 662568

Group type: EXPERIMENTAL
Intervention: Cold-pressor test (direct stimulation)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Observing a model exposed to the cold-pressor test (vicarious stimulation)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Hearing modeled verbal expressions of pain (vicarious stimulation)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Observing the model express neither verbal expressions nor physical movements (minimal modeling condition)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Direct stimulation vs. maximal modeling condition
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Two forms of modeling (observing and hearing pain expressions)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Direct stimulation and vicarious stimulation
Number of subjects: 0
Study: 7115241

Group type: EXPERIMENTAL
Intervention: Autogenic-feedback training (AFT) for highly susceptible subjects (Treatment Group I)
Number of subjects: 24

Group type: EXPERIMENTAL
Intervention: Autogenic-feedback training (AFT) for moderately susceptible subjects (Treatment Group II)
Number of subjects: 24

Group type: COMPARATOR
Intervention: Control group (highly susceptible, Control Group III)
Number of subjects: 24

Group type: COMPARATOR
Intervention: Control group (moderately susceptible, Control Group IV)
Number of subjects: 24
Study: 31420787

Group type: EXPERIMENTAL
Intervention: PL‐ASA 325 mg
Number of subjects: 32

Group type: EXPERIMENTAL
Intervention: PL‐ASA 650 mg
Number of subjects: 32

Group type: COMPARATOR
Intervention: IR‐ASA 325 mg
Number of subjects: 32

Group type: COMPARATOR
Intervention: IR‐ASA 650 mg
Number of subjects: 32

Group type: EXPERIMENTAL
Intervention: PL‐ASA
Number of subjects: 32

Group type: COMPARATOR
Intervention: IR‐ASA
Number of subjects: 32
Study: 28696772

Group type: EXPERIMENTAL
Intervention: Simulation condition (simulators)
Number of subjects: 90

Group type: COMPARATOR
Intervention: Control condition (controls)
Number of subjects: 90

Group type: EXPERIMENTAL
Intervention: Combined RT measures and immediate recognition (IR) subtest accuracy score
Number of subjects: 90
Study: 25826678

Group type: COMPARATOR
Intervention: Standard fluid administration (S-group)
Number of subjects: 60

Group type: EXPERIMENTAL
Intervention: Reduced fluid administration (R-group)
Number of subjects: 60
Study: 24890250

Group type: EXPERIMENTAL
Intervention: Public involvement intervention
Number of subjects: 172

Group type: EXPERIMENTAL
Intervention: Structured preparation meeting and access to population-based data
Number of subjects: 172

Group type: EXPERIMENTAL
Intervention: Small-group deliberations and wider public consultation
Number of subjects: 172

Group type: EXPERIMENTAL
Intervention: Engagement of key stakeholders in intervention design
Number of subjects: 172
Study: 22565511

Group type: EXPERIMENTAL
Intervention: Sprite with sodium fluoride
Number of subjects: 24

Group type: EXPERIMENTAL
Intervention: Sprite with calcium phosphate
Number of subjects: 24

Group type: COMPARATOR
Intervention: Original drink Sprite
Number of subjects: 24
Study: 21789881

Group type: EXPERIMENTAL
Intervention: 100 mg daily oral DHEA for 28 days
Number of subjects: 20

Group type: COMPARATOR
Intervention: Placebo (PLA) for 28 days
Number of subjects: 20
Study: 18007119

Group type: EXPERIMENTAL
Intervention: Structured strength and balance training (3 times a week for 10 weeks)
Number of subjects: 30

Group type: COMPARATOR
Intervention: Control group
Number of subjects: 30
Study: 16331852

Group type: EXPERIMENTAL
Intervention: Moderate dose of alcohol (0.65 g/kg)
Number of subjects: 20

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 20
Study: 11815423

Group type: EXPERIMENTAL
Intervention: Short-term estrogen administration (25 mg of conjugated equine estrogens IV)
Number of subjects: 54

Group type: EXPERIMENTAL
Intervention: Long-term hormone replacement therapy (HRT)
Number of subjects: 54

Group type: COMPARATOR
Intervention: Control group (12 young healthy women)
Number of subjects: 54

Group type: EXPERIMENTAL
Intervention: Long-term HRT (estrogen alone or with progestogen)
Number of subjects: 54

Group type: EXPERIMENTAL
Intervention: Women not taking HRT
Number of subjects: 54
Study: 10412515

Group type: EXPERIMENTAL
Intervention: rh-GH therapy (0.250 IU/Kg/week)
Number of subjects: 9

Group type: EXPERIMENTAL
Intervention: rh-GH therapy
Number of subjects: 9

Group type: COMPARATOR
Intervention: placebo
Number of subjects: 9
Study: 7748051

Group type: EXPERIMENTAL
Intervention: Angiotensin-converting enzyme inhibitors
Number of subjects: 14

Group type: EXPERIMENTAL
Intervention: Nondihydropyridine calcium antagonists
Number of subjects: 14

Group type: COMPARATOR
Intervention: Dihydropyridine calcium antagonists
Number of subjects: 14

Group type: COMPARATOR
Intervention: Blood pressure reduction (10 mm Hg)
Number of subjects: 14
Study: 1983711

Group type: EXPERIMENTAL
Intervention: silymarin
Number of subjects: 60

Group type: EXPERIMENTAL
Intervention: amino‐imidazol‐carboxamid‐phosphate
Number of subjects: 60

Group type: COMPARATOR
Intervention: placebo
Number of subjects: 60
Study: 6989556

Group type: EXPERIMENTAL
Intervention: Continuous transcutaneous oxygen (PtcO2) monitoring
Number of subjects: 10

Group type: COMPARATOR
Intervention: Estimation from arterial blood gas (PaO2)
Number of subjects: 10
Study: 31454046

Group type: COMPARATOR
Intervention: 400 IU Vitamin D3
Number of subjects: 311

Group type: EXPERIMENTAL
Intervention: 4000 IU Vitamin D3
Number of subjects: 311

Group type: EXPERIMENTAL
Intervention: 10,000 IU Vitamin D3
Number of subjects: 311
Study: 28776117

Group type: EXPERIMENTAL
Intervention: GnRH antagonist (0.25 mg/12 h) administered the day before hCG trigger
Number of subjects: 194

Group type: COMPARATOR
Intervention: Control group (no double dose of GnRH antagonist)
Number of subjects: 194
Study: 25619464

Group type: EXPERIMENTAL
Intervention: Home electrical stimulation (HES)
Number of subjects: 36

Group type: COMPARATOR
Intervention: Standardized biofeedback training (SBT)
Number of subjects: 36
Study: 23809945

Group type: EXPERIMENTAL
Intervention: Wavefront-guided with aspheric ablation
Number of subjects: 31

Group type: COMPARATOR
Intervention: Aspheric ablation only
Number of subjects: 31
Study: 21928117

Group type: COMPARATOR
Intervention: Household Environmental Tobacco Smoke Exposure (HH‐ETSE) among non-smokers
Number of subjects: 929

Group type: COMPARATOR
Intervention: Current smoking among smokers
Number of subjects: 929

Group type: COMPARATOR
Intervention: Household Environmental Tobacco Smoke Exposure (HH‐ETSE) as a mediator
Number of subjects: 929
Study: 19154566

Group type: EXPERIMENTAL
Intervention: B vitamin supplementation (0.8 mg folic acid, 0.5 mg cyanocobalamin, and 3 mg pyridoxine daily for 6 months)
Number of subjects: 65

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 65
Study: 17545174

Group type: EXPERIMENTAL
Intervention: Midazolam
Number of subjects: 56

Group type: COMPARATOR
Intervention: Diphenhydramine
Number of subjects: 56
Study: 15085374

Group type: EXPERIMENTAL
Intervention: Chemoreflex sensitivity (CHRS) measurement after electrical cardioversion
Number of subjects: 43

Group type: EXPERIMENTAL
Intervention: CHRS below 3.0 ms/mmHg
Number of subjects: 43

Group type: EXPERIMENTAL
Intervention: Follow-up after electrical cardioversion
Number of subjects: 43
Study: 11150025

Group type: EXPERIMENTAL
Intervention: unfractionated heparin
Number of subjects: 54

Group type: EXPERIMENTAL
Intervention: low‐molecular‐weight heparin
Number of subjects: 54

Group type: EXPERIMENTAL
Intervention: lepirudin
Number of subjects: 54

Group type: COMPARATOR
Intervention: placebo
Number of subjects: 54

Group type: EXPERIMENTAL
Intervention: all groups (including placebo)
Number of subjects: 54
Study: 9456420

Group type: EXPERIMENTAL
Intervention: Sublingual lorazepam (1 mg)
Number of subjects: 60

Group type: COMPARATOR
Intervention: Placebo tablet
Number of subjects: 60
Study: 7653747

Group type: EXPERIMENTAL
Intervention: 0.125% cetirizine nasal spray
Number of subjects: 360

Group type: EXPERIMENTAL
Intervention: 0.06% cetirizine nasal spray
Number of subjects: 360

Group type: EXPERIMENTAL
Intervention: 0.25% cetirizine nasal spray
Number of subjects: 360

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 360

Group type: EXPERIMENTAL
Intervention: All treatment groups
Number of subjects: 360
Study: 3670682

Group type: EXPERIMENTAL
Intervention: Thymomodulin (120 mg/die for 20 days/month for 4 months)
Number of subjects: 85

Group type: EXPERIMENTAL
Intervention: Thymomodulin in association with vaccine (120 mg/die for 20 days/month for 4 months)
Number of subjects: 85

Group type: COMPARATOR
Intervention: Antibiotic therapy
Number of subjects: 85

Group type: COMPARATOR
Intervention: Vaccine
Number of subjects: 85

Group type: COMPARATOR
Intervention: Association of vaccine-thymomodulin
Number of subjects: 85
Study: 31128008

Group type: EXPERIMENTAL
Intervention: Preoperative infusion chemotherapy combined with hyperthermia
Number of subjects: 136
Study: 28544926

Group type: EXPERIMENTAL
Intervention: Perspective-taking condition (participants who lost resources)
Number of subjects: 180

Group type: COMPARATOR
Intervention: High resources condition
Number of subjects: 180

Group type: COMPARATOR
Intervention: Low resources condition
Number of subjects: 180

Group type: COMPARATOR
Intervention: Lose resources condition
Number of subjects: 180

Group type: COMPARATOR
Intervention: Gain resources condition
Number of subjects: 180
Study: 25417775

Group type: EXPERIMENTAL
Intervention: Bevacizumab
Number of subjects: 1008

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 1008

Group type: EXPERIMENTAL
Intervention: Age
Number of subjects: 1008

Group type: EXPERIMENTAL
Intervention: VTE risk score
Number of subjects: 1008
Study: 23537608

Group type: EXPERIMENTAL
Intervention: Structured education protocol on transfer skills by physical and occupational therapists
Number of subjects: 70

Group type: EXPERIMENTAL
Intervention: Dependent transfer
Number of subjects: 70

Group type: COMPARATOR
Intervention: Standard therapy services
Number of subjects: 70
Study: 21596696

Group type: EXPERIMENTAL
Intervention: Carotid artery stenting (CAS)
Number of subjects: 22

Group type: COMPARATOR
Intervention: Purely diagnostic angiography (Control)
Number of subjects: 22
Study: 19425877

Group type: EXPERIMENTAL
Intervention: Open RT-CGM
Number of subjects: 12

Group type: COMPARATOR
Intervention: Blinded RT-CGM (Control)
Number of subjects: 12

Group type: EXPERIMENTAL
Intervention: Both groups
Number of subjects: 12

Group type: EXPERIMENTAL
Intervention: SMBG vs RT-CGM
Number of subjects: 12
Study: 16966188

Group type: EXPERIMENTAL
Intervention: d-amphetamine
Number of subjects: 101

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 101
Study: 12780755

Group type: EXPERIMENTAL
Intervention: Prednisolone (40 mg/m2)
Number of subjects: 19

Group type: EXPERIMENTAL
Intervention: Dexamethasone (6.5 mg/m2)
Number of subjects: 19
Study: 11214010

Group type: EXPERIMENTAL
Intervention: Thrombolytic treatment for acute myocardial infarction in left bundle branch block
Number of subjects: 257

Group type: EXPERIMENTAL
Intervention: Thrombolytic treatment for acute myocardial infarction in right bundle branch block
Number of subjects: 257

Group type: EXPERIMENTAL
Intervention: Mortality rates in patients with left bundle branch block
Number of subjects: 257

Group type: EXPERIMENTAL
Intervention: Mortality rates after one year
Number of subjects: 257
Study: 8939767

Group type: COMPARATOR
Intervention: Calcium (Ca)
Number of subjects: 189

Group type: COMPARATOR
Intervention: Vitamin D+Ca
Number of subjects: 189

Group type: COMPARATOR
Intervention: 1 of 2 doses of vitamin D+Ca
Number of subjects: 189

Group type: COMPARATOR
Intervention: Placebo (P)
Number of subjects: 189
Study: 1548519

Group type: EXPERIMENTAL
Intervention: FAMTX
Number of subjects: 60

Group type: COMPARATOR
Intervention: EAP
Number of subjects: 60
Study: 3976636

Group type: COMPARATOR
Intervention: 10 mg metoclopramide
Number of subjects: 93

Group type: COMPARATOR
Intervention: 20 mg metoclopramide
Number of subjects: 93

Group type: EXPERIMENTAL
Intervention: Placebo
Number of subjects: 93

Group type: COMPARATOR
Intervention: Both metoclopramide doses
Number of subjects: 93
Study: 31258019

Group type: EXPERIMENTAL
Intervention: Daily iron supplementation at a dose of 2 mg kg-1 from 36 hours of age (N=50, anemic mothers)
Number of subjects: 200

Group type: EXPERIMENTAL
Intervention: Daily iron supplementation at a dose of 2 mg kg-1 from 36 hours of age (N=50, non-anemic mothers)
Number of subjects: 200

Group type: EXPERIMENTAL
Intervention: Daily iron supplementation at a dose of 2 mg kg-1 from 36 hours of age (N=50, anemic and non-anemic mothers)
Number of subjects: 200

Group type: COMPARATOR
Intervention: No iron supplementation (N=50, anemic mothers)
Number of subjects: 200

Group type: COMPARATOR
Intervention: No iron supplementation (N=50, non-anemic mothers)
Number of subjects: 200

Group type: COMPARATOR
Intervention: No iron supplementation (N=50, anemic and non-anemic mothers)
Number of subjects: 200
Study: 31707815

Group type: EXPERIMENTAL
Intervention: Erenumab (70 mg or 140 mg)
Number of subjects: 2375

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 2375
Study: 30003634

Group type: EXPERIMENTAL
Intervention: Approach-Avoidance Training (AAT)
Number of subjects: 60

Group type: EXPERIMENTAL
Intervention: Episodic Future Thinking (EFT)
Number of subjects: 60

Group type: COMPARATOR
Intervention: Control
Number of subjects: 60
Study: 25872790

Group type: EXPERIMENTAL
Intervention: Colistin 4.5 MU as a loading dose, followed by 3 MU every eight hours, combined with levofloxacin
Number of subjects: 496

Group type: COMPARATOR
Intervention: Meropenem 2 g every eight hours, combined with levofloxacin
Number of subjects: 496
Study: 24225149

Group type: EXPERIMENTAL
Intervention: Usual care + smartphone application (Glucose Buddy) with weekly text-message feedback from a Certified Diabetes Educator
Number of subjects: 72

Group type: COMPARATOR
Intervention: Usual care (control group)
Number of subjects: 72
Study: 21128980

Group type: EXPERIMENTAL
Intervention: Autologous bone graft (Group A)
Number of subjects: 46

Group type: COMPARATOR
Intervention: No bone graft (Group B)
Number of subjects: 46
Study: 19561523

Group type: EXPERIMENTAL
Intervention: 3-week repeat pulmonary rehabilitation (PR) program
Number of subjects: 60

Group type: COMPARATOR
Intervention: Usual care (control group)
Number of subjects: 60
Study: 17405970

Group type: EXPERIMENTAL
Intervention: Sumatriptan-naproxen sodium (85 mg sumatriptan and 500 mg naproxen sodium)
Number of subjects: 2956

Group type: COMPARATOR
Intervention: Sumatriptan monotherapy
Number of subjects: 2956

Group type: COMPARATOR
Intervention: Naproxen sodium monotherapy
Number of subjects: 2956

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 2956
Study: 15234487

Group type: EXPERIMENTAL
Intervention: Female players
Number of subjects: 16

Group type: COMPARATOR
Intervention: Male players
Number of subjects: 16
Study: 11176979

Group type: EXPERIMENTAL
Intervention: Topical latanoprost for 3 months (n = 8)
Number of subjects: 17

Group type: COMPARATOR
Intervention: Alternative medication for 3 months (n = 9)
Number of subjects: 17
Study: 7941592

Group type: EXPERIMENTAL
Intervention: Keyhole Limpet Hemocyanin (KLH)
Number of subjects: 50

Group type: COMPARATOR
Intervention: Control group (no KLH treatment)
Number of subjects: 50
Study: 3282216

Group type: EXPERIMENTAL
Intervention: Chlorpheniramine
Number of subjects: 40

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 40
Study: 31707503

Group type: EXPERIMENTAL
Intervention: Home-exercise programme
Number of subjects: 24
Study: 29705155

Group type: COMPARATOR
Intervention: Telehealth
Number of subjects: 472

Group type: COMPARATOR
Intervention: Telephone support
Number of subjects: 472

Group type: EXPERIMENTAL
Intervention: Usual care
Number of subjects: 472
Study: 28096393

Group type: EXPERIMENTAL
Intervention: Utility-value intervention with parents
Number of subjects: 0
Study: 26817221

Group type: EXPERIMENTAL
Intervention: Laughing training program (3 days/week, 60 minutes/day for 8 weeks)
Number of subjects: 38

Group type: COMPARATOR
Intervention: Control group (no laughing training)
Number of subjects: 38
Study: 23205735

Group type: EXPERIMENTAL
Intervention: Human milk fortification
Number of subjects: 132

Group type: COMPARATOR
Intervention: Fortified group
Number of subjects: 132

Group type: EXPERIMENTAL
Intervention: Extremely low birth weight (ELBW) neonates
Number of subjects: 132
Study: 21450652

Group type: EXPERIMENTAL
Intervention: Exercise training
Number of subjects: 24

Group type: COMPARATOR
Intervention: Control group
Number of subjects: 24
Study: 18457786

Group type: EXPERIMENTAL
Intervention: Intervention group (FCs with monthly contact from Healthy Eating Coordinator)
Number of subjects: 12

Group type: COMPARATOR
Intervention: Control group (FCs without monthly contact from Healthy Eating Coordinator)
Number of subjects: 12
Study: 17238699

Group type: EXPERIMENTAL
Intervention: Online patient portal providing personalized information (Diabetes-STAR)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Online patient portal providing generic diabetes self-management information
Number of subjects: 0
Study: 12635790

Group type: EXPERIMENTAL
Intervention: Resorbable Shuttle Stop (HC Implants, BV. Leiden, The Netherlands)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Nonresorbable restrictor of polyethylene (De Puy, UK)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Both groups
Number of subjects: 0
Study: 11056238

Group type: EXPERIMENTAL
Intervention: Pronucleate (PN) zygotes
Number of subjects: 382

Group type: COMPARATOR
Intervention: Early-cleavage (EC) embryos
Number of subjects: 382